marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Brainstorm Cell Therapeutics Financial Statements 2011-2024 | BCLI
Annual Financial Statements Brainstorm Cell Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
31.9 M | 66.8 M | 145 M | 188 M | 88.1 M | 73.6 M | 67.6 M | 51.3 M | 45.5 M | 54.5 M | 43.5 M | 31.6 M | 26.4 M |
Shares |
43.1 M | 36.5 M | 36.2 M | 31.2 M | 21.9 M | 20 M | 18.8 M | 18.7 M | 18.4 M | 13.7 M | 10.7 M | 9.17 M | 8.01 M |
Historical Prices |
0.74 | 1.83 | 4 | 4.53 | 4.28 | 3.55 | 3.92 | 2.54 | 2.86 | 4.76 | 2.7 | 3.3 | 3.15 |
Net Income |
-17.2 M | -24.3 M | -24.5 M | -31.8 M | -23.3 M | -13.9 M | -4.95 M | -4.98 M | -8.49 M | -9.25 M | -4.9 M | -3.43 M | -3.92 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-21.4 M | -24.8 M | -24.5 M | -31.7 M | -23 M | -14.1 M | -5 M | -5.08 M | -8.54 M | -7.42 M | -4.9 M | -3.42 M | -3.91 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | -93 K | -151 K |
EBITDA |
-21.2 M | -24.5 M | -24.3 M | -31.5 M | -22.8 M | -14 M | -4.91 M | -5.01 M | -8.54 M | -7.42 M | -5.02 M | -3.52 M | -3.74 M |
Operating Expenses |
- | - | - | 31.7 M | 23 M | 14.1 M | 5 M | 5.08 M | 8.54 M | 7.42 M | 5.02 M | 3.52 M | 3.89 M |
General and Administrative Expenses |
10.7 M | 10.9 M | 9.3 M | 9.36 M | 5.8 M | 5.77 M | 4.02 M | 2.83 M | 3.59 M | 2.65 M | 2.1 M | 1.75 M | 2.2 M |
All numbers in USD currency
Quarterly Income Statement Brainstorm Cell Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
71.2 M | 64.7 M | 60.5 M | 44.3 M | 39.7 M | 36.7 M | 36.7 M | 36.5 M | 36.5 M | 36.4 M | 36.4 M | 36.3 M | 36.3 M | 35.8 M | 35.2 M | 31.2 M | 29.3 M | 28.4 M | 23.2 M | 22.3 M | 21.7 M | 20.9 M | 20.8 M | 20.7 M | 19.5 M | 19 M | 19 M | 18.8 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.6 M | 18.5 M | 18.5 M | 18.1 M | 15.3 M | 15.2 M | 12.4 M | 11.8 M | 11.8 M | 10.9 M | 153 M | 151 M | 150 M | 145 M | 128 M | 127 M | 126 M | 125 M | 121 M | 126 M |
Net Income |
-2.54 M | -3.4 M | - | -1.23 M | -5.33 M | -5.06 M | - | -6.86 M | -7.04 M | -5.36 M | - | -5.34 M | -6.27 M | -6.66 M | - | -4.49 M | -7.39 M | -8.11 M | - | -5.63 M | -23.3 M | -23.3 M | - | -13.9 M | -13.9 M | -13.9 M | - | -4.95 M | -4.95 M | -4.95 M | - | -4.98 M | -4.98 M | -4.98 M | - | -8.49 M | -8.49 M | -8.49 M | - | -9.25 M | -9.25 M | -9.25 M | - | -4.9 M | -4.9 M | -4.9 M | - | -3.43 M | -3.43 M | -3.43 M | - | -3.92 M | -3.92 M | -3.92 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.98 M | -2.47 M | - | -6.04 M | -5.45 M | -5.15 M | - | -6.84 M | -7.59 M | -5.48 M | - | -5.28 M | -6.12 M | -6.93 M | - | -4.48 M | -7.4 M | -8.31 M | - | -5.55 M | -4.86 M | -4.93 M | - | -3.23 M | -3.09 M | -2.31 M | - | -2.39 M | -1.08 M | -1.77 M | - | -1.64 M | -983 K | -1.81 M | - | -2.57 M | -2.36 M | -2.2 M | - | -2.43 M | -1.29 M | -2.11 M | - | -1.08 M | -1.5 M | -1.08 M | - | -1.15 M | -829 K | -868 K | - | -694 K | 1.09 M | 705 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 K | - | -22 K | 4 K | -11 K | - | -46 K | 191 K | -177 K |
EBITDA |
-2.92 M | -2.41 M | - | -5.97 M | -5.38 M | -5.08 M | - | -6.77 M | -7.52 M | -5.4 M | - | -5.21 M | -6.06 M | -6.87 M | - | -4.43 M | -7.35 M | -8.26 M | - | -5.51 M | -4.82 M | -4.88 M | - | -3.2 M | -3.06 M | -2.28 M | - | -2.37 M | -1.06 M | -1.75 M | - | -1.62 M | -961 K | -1.8 M | - | -2.57 M | -2.36 M | -2.2 M | - | -2.43 M | -1.29 M | -2.11 M | - | -1.08 M | -1.5 M | -1.08 M | - | -1.15 M | -829 K | -868 K | - | -694 K | 1.09 M | 705 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.2 M | - | 2.43 M | 1.29 M | 1.03 M | - | 1.08 M | 1.48 M | 1.08 M | - | 1.17 M | 833 K | 879 K | - | 740 K | 1.42 M | 528 K |
General and Administrative Expenses |
2.06 M | 1.51 M | - | 2.7 M | 2.66 M | 2.23 M | - | 3.06 M | 2.48 M | 2.86 M | - | 1.66 M | 2.52 M | 2.59 M | - | 2.62 M | 1.71 M | 2.36 M | - | 1.54 M | 1.3 M | 1.47 M | - | 1.26 M | 1.61 M | 1.33 M | - | 1.22 M | 640 K | 829 K | - | 848 K | 832 K | 826 K | - | 1.07 M | 988 K | 960 K | - | 858 K | 417 K | 351 K | - | 272 K | 743 K | 559 K | - | 440 K | 448 K | 510 K | - | 564 K | 829 K | 258 K |
All numbers in USD currency